Sue S. Yom, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Sue S. Yom, MD, PhD

Associate Professor, Department of Radiation Oncology, UCSF

Phone: (415) 353-9807 (appts)
Box 1708, UCSF
San Francisco, CA 94143-1708

View on UCSF Profiles

Cancer Center Membership

Program Member » Developmental Therapeutics

Research Summary

I am an expert in the study of head and neck, cutaneous, and thoracic cancer outcomes. I am an experienced clinical trialist, having developed numerous single and multi-institutional studies in supportive care, as well as combinations of radiation therapy with a variety of radiosensitizing systemic agents. I also have special interests in quality of life and patient decision-making support. I serve on a number of committees that develop guidelines for quality care in my areas.

Education

2002, University of Pennsylvania, Philadelphia, PA, M.D., Ph.D., Medicine/English
2003, U. T. – M. D. Anderson Cancer Center, Internship, Medicine/Surgery
2007, U. T. – M. D. Anderson Cancer Center, Residency, Radiation Oncology


Professional Experience

  • 2007-2013
    Assistant Professor of Clinical Radiation Oncology, University of California, San Francisco
  • 2007-present
    Consultant in Radiology, San Francisco Veterans Administration Medical Center
  • 2008-2013
    Assistant Professor in Otolaryngology-Head and Neck Surgery, by courtesy
  • 2013-present
    Associate Professor of Clinical Radiation Oncology, University of California, San Francisco
  • 2013-present
    Associate Professor in Otolaryngology-Head and Neck Surgery, by courtesy

Honors & Awards

  • 1992
    Mellon Fellow in the Humanities, Andrew W. Mellon Foundation
  • 1995
    Benjamin Franklin Medical Scholar Fellowship, University of Pennsylvania
  • 2004
    Thomas Barkley Award, M. D. Anderson Cancer Center
  • 2005
    Fellowship, Korean American Society for Therapeutic Radiology & Oncology
  • 2006
    Jesse H. Jones Fellowship in Cancer Education, M. D. Anderson Cancer Center
  • 2006
    Outstanding Resident Presentation Award, Texas Radiological Society
  • 2006
    A. Lavoy Moore Endowment Fund, M. D. Anderson Cancer Center
  • 2006
    Eleanor Montague Distinguished Resident Award, American Association of Women Radiologists
  • 2008
    Joan F. Giambalvo Memorial Scholarship, AMA Women Physicians Congress
  • 2009
    Best Doctors in America, 2009-2014
  • 2011
    Educator of the Year Award, Association of Residents in Radiation Oncology

Selected Publications

  1. ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Head Neck. 2016 Feb; 38(2):175-82.
    View on PubMed
  2. Elective versus Therapeutic Neck Dissection in Oral Cancer. N Engl J Med. 2015 Dec 17; 373(25):2476.
    View on PubMed
  3. HPV and oropharyngeal cancer: etiology and prognostic importance. Semin Cutan Med Surg. 2015 Dec; 34(4):178-81.
    View on PubMed
  4. Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder. Int J Radiat Oncol Biol Phys. 2015 Dec 1; 93(5):986-8.
    View on PubMed
  5. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):847-56.
    View on PubMed
  6. Radiation treatment of head and neck cancer. Surg Oncol Clin N Am. 2015 Jul; 24(3):423-36.
    View on PubMed
  7. Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma. Br J Dermatol. 2015 Aug; 173(2):544-6.
    View on PubMed
  8. Prognostic significance of hyoid bone invasion in advanced base of tongue carcinoma treated by chemoradiation. Clin Otolaryngol. 2015 Jun; 40(3):260-5.
    View on PubMed
  9. Consolidative radiation therapy for extensive-stage small cell lung cancer. Transl Lung Cancer Res. 2015 Jun; 4(3):211-4.
    View on PubMed
  10. The Limitations of Routine Magnetic Resonance Imaging for Long-Term Post-Treatment Locoregional Surveillance of Salivary Carcinoma. ORL J Otorhinolaryngol Relat Spec. 2015; 77(3):132-40.
    View on PubMed
  11. Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study. Int J Radiat Oncol Biol Phys. 2015 Jun 1; 92(2):220-7.
    View on PubMed
  12. Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: Insights from lung tumor patients treated with robotic radiosurgery. Med Phys. 2015 Mar; 42(3):1280.
    View on PubMed
  13. Reply to d. Adkins et Al. J Clin Oncol. 2015 Apr 1; 33(10):1224-5.
    View on PubMed
  14. The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma. Am J Otolaryngol. 2015 May-Jun; 36(3):415-23.
    View on PubMed
  15. Molecular determinants of radiation response in non-small cell lung cancer. Semin Radiat Oncol. 2015 Apr; 25(2):67-77.
    View on PubMed
  16. Accelerated repopulation as a cause of radiation treatment failure in non-small cell lung cancer: review of current data and future clinical strategies. Semin Radiat Oncol. 2015 Apr; 25(2):93-9.
    View on PubMed
  17. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol. 2014; 9:269.
    View on PubMed
  18. Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma. Laryngoscope. 2015 Apr; 125(4):869-76.
    View on PubMed
  19. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy. Technol Cancer Res Treat. 2015 Feb; 14(1):49-60.
    View on PubMed
  20. Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician. Semin Oncol. 2014 Dec; 41(6):764-75.
    View on PubMed

Go to UCSF Profiles, powered by CTSI